Physician profile
Robert A Raines
NPI 1427040831
$3,128.79
in general payments reported to CMS, 2019-2025
12 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $119 · 2021: $68.77 · 2022: $360 · 2023: $232 · 2024: $1,346 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Travel and Lodging: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.03 |
| Travel and Lodging | $858.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $719.23 | 2021-2025 | Infinity Adaptis, Ortholoc 3di, Pangea |
| Legacy Ortho LLC | $545.26 | 2024 | |
| Wright Medical Technology, INC. | $514.25 | 2019 | |
| Arthrex, INC. | $451.35 | 2024 | |
| Smith+Nephew, INC. | $430.34 | 2020-2025 | Evos, Cadence, Vlp Foot |
| Treace Medical Concepts, INC. | $186.84 | 2022-2025 | |
| Integra Lifesciences Corporation | $119.32 | 2019-2020 | |
| Sanara Medtech INC. | $47.76 | 2025 | Celleraterx |
| Depuy Synthes Sales INC. | $43.40 | 2020 | |
| Abbvie INC. | $30.34 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.00 | 2025 | Zilretta |
| Saluda Medical Americas, INC. | $18.70 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Raines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.